US Markets
AZN

AstraZeneca says COVID-19 vaccine trial in U.S still on hold

Credit: REUTERS/DADO RUVIC

AstraZeneca Plc said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.

Sept 19 (Reuters) - AstraZeneca Plc AZN.L said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.

AstraZeneca on Saturday published a document describing details of how the COVID-19 vaccine trial was being carried out, which was first reported by the New York Times. https://nyti.ms/3mzCmdb

(Reporting by Rama Venkat in Bengaluru; Editing by Michael Perry)

((ramavenkat.raman@thomsonreuters.com; https://twitter.com/ramavenkat0607;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AZN

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More